Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06851325 · ClinicalTrials.gov registry record
Antiplatelets and Intramyocardial Hemorrhage in STEMI: Incidence and Outcomes
A clinical trial of Acute Myocardial Infarction and STEMI, sponsored by Rohan Dharmakumar.
- Completed
- Registry status
- 6,180
- Enrollment target
- 1
- Study location
NCT06851325: Completed study of Acute Myocardial Infarction and STEMI, sponsored by Rohan Dharmakumar.
NCT06851325 is a study of Acute Myocardial Infarction and STEMI that has completed, run by Rohan Dharmakumar. The registered enrollment target is 6,180 participants, above the 1,557-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (297% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06851325, a study of Acute Myocardial Infarction and STEMI, has completed, sponsored by Rohan Dharmakumar.
- COMPLETED
- Registry status
- 6,180 participants
- Enrollment target
- 1
- Study location
Study Summary
The MIRON-PLATELET study is a retrospective, observational multi-center analysis assessing the impact of different antiplatelet therapies on hemorrhagic myocardial infarction (HMI) incidence and outcomes in STEMI patients. Key endpoints include hemorrhagic transformation, MACE, bleeding complications, and 30-day mortality. Findings will offer insights into the safety and clinical implications of antiplatelet therapy in high-risk patients.
Primary Outcome
Risk ratio assessment of the occurrence of hemorrhagic transformation in STEMI patients treated with different antiplatelet regimens.
Conditions Studied
Study Locations (1)
Indiana
- Medical Imaging Research Institute - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,180 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2025-02-11 |
What the finished NCT06851325 record still lists
NCT06851325 is an observational study that tracks outcomes without assigning an intervention. Its 6,180 participants enrollment target places it among the larger protocols in the corpus, above the 1,557-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (297% higher).
The record links to 2 conditions, with Acute Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.
NCT06851325 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT06851325 about?
NCT06851325 is a clinical study titled "Antiplatelets and Intramyocardial Hemorrhage in STEMI: Incidence and Outcomes". The MIRON-PLATELET study is a retrospective, observational multi-center analysis assessing the impact of different antiplatelet therapies on hemorrhagic myocardial infarction (HMI) incidence and outcomes in STEMI patients. Key endpoints include hemorrhagic transformation, MACE, bleeding complication...
What is the current status of trial NCT06851325?
This trial is currently completed. The enrollment target is 6,180 participants. The study started on 2023-05-01. Estimated completion is 2025-02-11.
What conditions does trial NCT06851325 study?
This clinical trial studies the following conditions: Acute Myocardial Infarction, STEMI.
Who is sponsoring clinical trial NCT06851325?
This trial is sponsored by Rohan Dharmakumar, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06851325 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06851325's enrollment target sits among peer trials
6,180 2nd of 19 the highest of 19 other Acute Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
RECRUITING · NA
-
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
RECRUITING
-
Abbott Vascular Medical Device Registry
RECRUITING
-
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
RECRUITING · NA
-
Arrhythmia Detection After MI
RECRUITING · NA
-
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07049861 · 6,200 participants · NA
Advancing Biopsychosocial Care Training Initiative
- NCT04774159 · 6,150 participants · Phase 3
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- NCT06304168 · 6,150 participants
Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study
- NCT03960099 · 6,250 participants · NA
Pictographs for Preventing Wrong-Patient Errors in NICUs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI